G. Kwok

PEG-BCT-100 in Combination With Capecitabine and Oxaliplatin (PACOX) in Patients With Advanced Hepatocellular Carcinoma: A Phase I Study Results

J. Chiu, T. Yau, P. Cheng, 2021 .

Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study

Bryan M. Li, J. Chiu, T. Yau, 2021, Postgraduate Medical Journal.

Outcomes of tyrosine kinase inhibitors (TKI) after immunotherapy in unresectable or advanced hepatocellular carcinoma (HCC) patients.

J. Chiu, T. Yau, T. Cheung, 2019, Journal of Clinical Oncology.

Nivolumab/pembrolizumab in Child-Pugh grade B/C patients with advanced HCC.

J. Chiu, T. Yau, T. Cheung, 2021 .

Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy

J. Chiu, T. Yau, A. Kwong, 2019, Postgraduate Medical Journal.